Quantcast

Latest Morphinans Stories

2014-10-23 16:25:56

Entrenchment of Current Analgesics and Increasing Cost Sensitivity Will Hamper Uptake of Emerging Acute Pain Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 23, 2014 /PRNewswire/ -- Decision Resources Group finds that the acute pain market will grow minimally from $12.7 billion in 2013 to $13.3 billion in 2023 across the major pharmaceutical markets (United States, France, Germany, Italy, Spain, the United Kingdom and Japan), representing an annual...

2014-10-22 08:32:56

Pain Insights, Inc. releases a comprehensive market research study on the impact of hydrocodone rescheduling, Zohydro(TM) ER, and abuse-deterrent formulations on prescribers and the pain market. FAIRFIELD, N.J., Oct. 22, 2014 /PRNewswire/ -- Rescheduling of hydrocodone combination products (HCPs) will impel a major transformation in the pain market, according to a new primary market research study by Pain Insights, Inc., a firm providing market research and consultation exclusively in the...

2014-10-21 08:33:43

Company's new identity to reflect its enhanced focus in chronic diseases of addiction RICHMOND, Va., Oct. 21, 2014 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc. (RBP) today announced its UK-based parent company, Reckitt Benckiser Group plc (RB), expects the proposed demerger of the RBP business to complete in 2014. Reckitt Benckiser originally announced plans to demerge the RBP business in late July 2014, and the operational and financial separations, appointment of the new...

2014-10-13 23:00:35

PAINWeekEnd Irvine presents a full day of pain management CME and takes place on Saturday, October 25 at the Irvine Marriott. Montclair, NJ (PRWEB) October 14, 2014 There are 116 million people in pain. There are 4,000 pain specialists. That’s 29,000 patients per pain specialist. There are simply not enough pain specialists to go around. What can primary care clinicians do to meet the challenges of this growing public health issue? Attend PAINWeekEnd Irvine on Saturday, October 25, at...

2014-10-13 20:22:44

BOCA RATON, Fla., Oct. 13, 2014 /PRNewswire/ -- TransMedia Group said it will publicize and market book rights and the completed movie script based on the true story behind the $40 million pill mill scheme operating out of pain management clinics in South Florida from 2008 to 2011. The script titled "Prescription For Death" tells how identical twins Christopher and Jeffrey George, now serving lengthy prison sentences, pulled off the nation's largest pill mill operation that killed...

2014-10-09 08:28:41

Butrans® is now available for prescribing in five dosage strengths STAMFORD, Conn., Oct. 9, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced the U.S. commercial launch of the new 7.5 mcg/hour dosage strength of Butrans(®) (buprenorphine) Transdermal System CIII. Five strengths of Butrans are now available: 5 mcg/hour, 7.5 mcg/hour, 10 mcg/hour, 15 mcg/hour and 20 mcg/hour. http://photos.prnewswire.com/prnvar/20100921/NY67262 Butrans is the first transdermal system that delivers seven days...

2014-10-07 23:01:09

Position Statement Authored by American Academy of Clinical Toxicology, American College of Medical Toxicology and American Association of Poison Control Centers Alexandria, VA (PRWEB) October 07, 2014 On Oct. 6, 2014, the American Association of Poison Control Centers (AAPCC), joined with the American Academy of Clinical Toxicology (AACT) and American College of Medical Toxicology (ACMT), to jointly publish a position statement advocating expanding the access to naloxone throughout the...

2014-10-07 08:29:31

Helping eligible opioid dependent patients in need MORRISTOWN, N.J., Oct. 7, 2014 /PRNewswire/ -- As part of our ongoing commitment to addiction medicine, Orexo US, Inc. (Orexo) announced the launch of a Patient Assistance Program (PAP) for ZUBSOLV(®) (buprenorphine and naloxone) sublingual tablet (CIII). This program provides ZUBSOLV free of charge to eligible opioid dependent patients in need. At this time, 1,000 patients who meet the program eligibility criteria will be allowed to...

2014-10-06 20:23:33

Conference Call Scheduled for Tuesday, October 7 at 8:00 AM Eastern Time RALEIGH, N.C., Oct. 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) will host an investor update conference call and webcast to discuss the launch of BUNAVAIL(TM) (buprenorphine and naloxone) buccal film (CIII) which has been approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of opioid dependence. The conference call and webcast will...

2014-10-06 12:29:49

New white paper released as hydrocodone is reclassified as a Schedule II drug ITASCA, Ill., Oct. 6, 2014 /PRNewswire-USNewswire/ -- Today the National Safety Council released a white paper, Evidence for the efficacy of pain medications, compiling research showing the combination of over-the-counter pain medications ibuprofen and acetaminophen are more effective at treating acute pain than opioid painkillers. As patients find that they are unable to refill their hydrocodone...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin